According to a news release just issued by Queen’s University, Belfast, a group of 150 researchers around the world is coming together to expand enrollment and access to the Australian INTERVAL trial into a global trial to test whether serious exercise should be prescribed as part of the treatment for men with advanced prostate cancer. Read the article.
Abiraterone acetate is poised to challenge docetaxel as the standard addition to androgen deprivation therapy for treatment of newly diagnosed, metastatic castration-resistant prostate cancer. Read the article here.
Researchers at the Technical University of Munich have discovered they can predict drug resistance in patients with advanced prostate cancer using a new blood test. Read the article here.
Prostate cancer in men that was previously thought to be incurable could now be treated. New research has discovered that using a specialised form of radiotherapy could allow them to kill the disease off. Read the article here.
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while protecting healthy tissue and reducing side effects. Read the article here.
A new study suggests that combining a breast cancer drug with hormone therapy could be a more effective strategy to reduce the progression and recurrence of prostate cancer in men. Read the article here.
Cleveland Clinic prostate cancer specialists tailor prostate cancer treatment plans to their patients’ needs, taking into account the type of cancer, the age of the individual, the degree to which the cancer has spread and the general health of the patient. Read the Guide here.
For men who are weighing the pros and cons of prostate cancer screening, a new study strengthens the evidence that testing can reduce deaths from this cancer, something two earlier large landmark clinical trials appeared to reach different conclusions about. Read the article here.